Sign in

NCT07023926Recruiting

The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine

The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine: a Pilot Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 14 Sept 2026

Brief summary (registry, in English)

Acupuncture is commonly used for the prevention of migraine and tension-type headaches, and has been found to be effective in reducing both the frequency and severity of these conditions. However, studies on acupuncture for menstrually related migraine (MRM) are limited, and current research has not been able to determine whether its efficacy is due to the actual therapeutic effects of acupuncture or psychological benefits. To address this issue, the investigators have designed a clinical trial to evaluate the efficacy of acupuncture for MRM.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
29 May 2025
Start date
1 Jul 2025
Primary completion date
31 Dec 2027
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Diseases
Migraine
NCT number
NCT07023926

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Jul 2025 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • receipt of preventive treatment for headache within 1 month prior to the screening visit;
  • afraid of needles or received acupuncture treatment within 3 months;

Other illness

  • presence of secondary headache disorders, facial neuralgia, or cranial neuralgia;
  • combined with serious primary diseases such as cardiovascular, hepatic, renal, gastrointestinal, or hematological disorders that may interfere with the treatment protocol, or comorbid neurological conditions such as epilepsy, parkinson's disease, or other central nervous system disorders;
  • headache symptoms caused by other conditions, such as moderate to severe head or neck trauma, perimenstrual infections, intracranial tumors, intracranial infections, endocrine or metabolic disorders;
  • unwillingness to undergo the study intervention or failure to sign the informed consent.

Other

  • irregular menstrual cycles, defined as cycle length outside the range of 28±7 days or menstruation duration \<3 days or \>7 days;

Who the study is looking for

  • meet the diagnostic criteria for MRM according to the ICHD-3, with a documented history of MRM for at least 12 months;
  • have a confirmed diagnosis of migraine by a neurologist;
  • aged 18-45 years;
  • have regular menstrual cycles (28 ± 7 days) with menstruation lasting 3-7 days;
  • have experienced ≥3 headache days during each menstrual cycle (days -2 to +3) and ≥5 total headache days per cycle over the past 3 months and baseline period; migraine attacks must last 4-72 hours without acute medication, or at least 2 hours when treated;
  • have completed a headache diary during the screening period (covering at least one full menstrual cycle), demonstrating good compliance;
  • headache diary data during screening period must meet the ICHD-3 criteria for MRM and fulfill criteria (4) and (5);
  • voluntarily sign the informed consent.

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Acupuncture, China Academy of Chinese Medical Sciences Guang'anmen Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.